Corticobasal Degeneration
- PMID: 12628064
- DOI: 10.1007/s11940-003-0006-z
Corticobasal Degeneration
Abstract
Corticobasal degeneration is one of the neurodegenerative tauopathies, which are defined as a group of heterogeneous dementias and movement disorders that are characterized neuropathologically by prominent intracellular accumulations of abnormal filaments formed by the microtubule-associated protein tau. Although there are no curative treatments, symptomatic and supportive management can be helpful. Many new therapies are still under development. However, more needs to be learned about the pathogenesis and molecular biology of this disease before an effective therapy can be developed.
Similar articles
-
Mutations causing neurodegenerative tauopathies.Biochim Biophys Acta. 2005 Jan 3;1739(2-3):240-50. doi: 10.1016/j.bbadis.2004.08.007. Biochim Biophys Acta. 2005. PMID: 15615642 Review.
-
Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.Neuropathology. 2006 Oct;26(5):475-83. doi: 10.1111/j.1440-1789.2006.00669.x. Neuropathology. 2006. PMID: 17080728
-
New classification of tauopathies.Rev Neurol (Paris). 2018 Nov;174(9):664-668. doi: 10.1016/j.neurol.2018.07.001. Epub 2018 Aug 8. Rev Neurol (Paris). 2018. PMID: 30098799 Review.
-
Disease-modifying therapies for tauopathies: agents in the pipeline.Expert Rev Neurother. 2019 May;19(5):397-408. doi: 10.1080/14737175.2019.1606715. Epub 2019 Apr 25. Expert Rev Neurother. 2019. PMID: 30973276 Review.
-
Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.Neuron. 2002 Aug 1;35(3):433-46. doi: 10.1016/s0896-6273(02)00789-4. Neuron. 2002. PMID: 12165467
References
LinkOut - more resources
Full Text Sources